Veterinary compounding looks like an extension of human sterile and non-sterile compounding, but the regulatory framework underneath it is different in ways that trip up pharmacists who assume the same rules apply. Federal extralabel drug use rules, a valid veterinarian-client-patient relationship, and state-specific board interpretations all stack together — and the scope of what a pharmacist can compound depends on all three at once.
The federal layer: AMDUCA and extralabel use
The Animal Medicinal Drug Use Clarification Act (AMDUCA) is what allows veterinarians to prescribe, and pharmacists to dispense, drugs for uses not listed on the FDA-approved label — extralabel use — for animals. Without AMDUCA, using a human or animal drug outside its approved label for a veterinary patient would generally not be permitted.
AMDUCA extralabel use is only lawful within a valid veterinarian-client-patient relationship (VCPR) — meaning a licensed veterinarian has examined the animal (or is otherwise sufficiently familiar with it) and is available for follow-up. A compounded prescription written outside a valid VCPR generally falls outside AMDUCA’s protection, regardless of how the compound itself was prepared.
AMDUCA also restricts compounding from bulk drug substances for food-producing animals more tightly than for companion animals, because of residue and food-safety concerns. FDA guidance (GFI #256) outlines the substances FDA generally does not intend to take enforcement action against when compounded from bulk for office use in certain circumstances — but this guidance doesn’t create a blanket allowance, and pharmacists compounding for food-producing animals should confirm current FDA guidance before doing so.
Where state board rules layer on top
AMDUCA sets the federal floor, but state boards of pharmacy regulate the actual practice of compounding within their state — and state rules can be more restrictive than federal law, though generally not less restrictive. A pharmacist compounding veterinary preparations needs to satisfy both:
- The state’s non-sterile and sterile compounding standards (often built on USP General Chapters 795, 797, and 800)
- Any state-specific veterinary compounding provisions, which some boards address explicitly and others don’t address at all
Some states require specific recordkeeping for veterinary compounds distinguishing them from human prescriptions. Others require the compounding pharmacist to document the VCPR basis for the prescription. Because this varies by state, confirm current requirements with your state board before establishing a veterinary compounding practice.
Species-specific dosing is a real scope issue, not just clinical detail
Compounding for veterinary patients involves dosing ranges, formulation stability, and excipient safety data that differ meaningfully from the human compounding literature most pharmacists train on. Some excipients that are safe in humans and dogs are toxic in cats (xylitol is a well-known example); some flavoring agents used to improve palatability for one species are inappropriate for another.
This matters for scope because a pharmacist compounding outside their competence in species-specific formulation isn’t just a clinical risk — it can also implicate the standard-of-practice requirements built into state pharmacy practice acts, which generally require compounding to be within the pharmacist’s demonstrated competence. Reference materials specific to veterinary compounding (rather than adapted human compounding references) are widely considered part of maintaining that competence.
Compounding from bulk vs. compounding from an FDA-approved drug
There’s a meaningful scope distinction between:
Compounding from an FDA-approved drug product — for example, altering a human tablet into a flavored suspension for a dog. This is generally permitted under AMDUCA extralabel use rules when a valid VCPR exists and no FDA-approved veterinary alternative is reasonably available.
Compounding from bulk drug substances — building a preparation from raw active pharmaceutical ingredient rather than an approved finished drug. This is more tightly restricted, particularly for food-producing animal patients, and pharmacies doing bulk compounding for veterinary use should have a clear understanding of which substances current FDA guidance addresses.
For the broader 503A/503B distinction that also applies in the veterinary context, see our guide to 503A vs. 503B compounding differences.
Recordkeeping specific to veterinary prescriptions
Veterinary prescriptions typically require documentation beyond what’s needed for a human prescription — the species, and often the specific animal’s identifying information (especially for controlled substances, where DEA recordkeeping requirements apply regardless of whether the patient is human or animal). Controlled substance compounding for animals also triggers the same DEA registration and recordkeeping obligations as human controlled substance dispensing.
Pharmacies that compound regularly for veterinary practices should also have a clear process for verifying the VCPR is current and documented — some state boards have specifically flagged failure to verify VCPR as a compliance gap in veterinary compounding audits.
A practical starting checklist
Before establishing or expanding a veterinary compounding practice, pharmacists generally need to confirm:
- Current FDA guidance on bulk compounding for the species and substance involved
- State board compounding standards (sterile and non-sterile) as applied to veterinary preparations
- Whether the state has veterinary-specific recordkeeping or VCPR documentation requirements
- Species-specific formulation and excipient safety references appropriate to the patient
- DEA registration and recordkeeping requirements if controlled substances are involved
Requirements in this area shift as FDA guidance and state board interpretations evolve, so confirm current rules with your state board of pharmacy and current FDA guidance before compounding for veterinary patients. For a broader overview of veterinary pharmacy compliance, see our veterinary pharmacy compliance guide and the glossary entry on extralabel drug use.
RxByState tracks state-specific compounding and veterinary practice rules alongside your license and CE requirements. Start a free trial →